学术探索
学术期刊
新闻热点
数据分析
智能评审

THE POLYMORPHIC OXIDATION OF BETA-ADRENOCEPTOR ANTAGONISTS - CLINICAL PHARMACOKINETIC CONSIDERATIONS

被引：82
作者：
LENNARD, MS
TUCKER, GT
WOODS, HF
机构：
来源：
CLINICAL PHARMACOKINETICS | 1986年 / 11卷 / 01期
关键词：
D O I：
10.2165/00003088-198611010-00001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1 / 17
页数：17
相关论文
共 93 条
[41]   THE EFFECT OF IMPAIRED RENAL-FUNCTION ON THE PLASMA-CONCENTRATION AND URINARY-EXCRETION OF METOPROLOL METABOLITES [J].
HOFFMANN, KJ ;
REGARDH, CG ;
AURELL, M ;
ERVIK, M ;
JORDO, L .
CLINICAL PHARMACOKINETICS, 1980, 5 (02) :181-191
[42]   A HUMAN CYTOCHROME-P-450 CHARACTERIZED BY INHIBITION STUDIES AS THE SPARTEINE DEBRISOQUINE MONOOXYGENASE [J].
INABA, T ;
NAKANO, M ;
OTTON, SV ;
MAHON, WA ;
KALOW, W .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1984, 62 (07) :860-862
[43]   DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINE [J].
INABA, T ;
OTTON, SV ;
KALOW, W .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) :547-549
[44]  
IYUN AO, 1986, BRIT J CLIN PHARM
[45]   LACK OF EVIDENCE FOR POLYMORPHISM IN METOPROLOL METABOLISM [J].
JACK, DB ;
WILKINS, M ;
QUARTERMAN, CP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (02) :188-190
[46]  
JACK DB, 1984, EUROPEAN J CLIN PHAR, V25, P569
[47]  
JACKSON PR, 1984, BRIT J CLIN PHARMACO, V18, pP306
[48]  
JOHNSSON G, 1976, Clinical Pharmacokinetics, V1, P233
[49]  
JOHNSSON G, 1980, INT J CLIN PHARM TH, V18, P292
[50]   ASSAY AND CHARACTERIZATION OF DEBRISOQUINE 4-HYDROXYLASE ACTIVITY OF MICROSOMAL FRACTIONS OF HUMAN-LIVER [J].
KAHN, GC ;
BOOBIS, AR ;
MURRAY, S ;
BRODIE, MJ ;
DAVIES, DS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (05) :637-645
12345678910